Zobrazeno 1 - 10
of 27
pro vyhledávání: '"V A, Tzingounis"'
Autor:
E, Cardamakis, A, Georgopoulos, A, Fotopoulos, G P, Sykiotis, A P, Pappas, D, Lazaris, V A, Tzingounis
Publikováno v:
The European journal of contraceptionreproductive health care : the official journal of the European Society of Contraception. 7(1)
This study was undertaken to assess the efficacy, acceptability and side-effects of the Norplant (Leiras) contraceptive system during adolescence.A total of 13 adolescents were implanted with Norplant immediately after menstruation. Adolescents were
Autor:
N A, Georgopoulos, K B, Markou, A P, Pappas, A, Protonatariou, G A, Vagenakis, G P, Sykiotis, P A, Dimopoulos, V A, Tzingounis
Publikováno v:
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology. 15(6)
Hypothalamic amenorrhea is a treatable cause of infertility. Our patient was presented with secondary amenorrhea and diabetes insipidus. Cortisol and prolactin responded normally to a combined insulin tolerance test (ITT) and thyrotropin-releasing ho
Autor:
V. A. Tzingounis, E. Cardamakis
Publikováno v:
Annals of the New York Academy of Sciences. 816
Publikováno v:
Clinical and experimental obstetricsgynecology. 22(1)
The evidence related to the effects of Ocs on the breast benign diseases and their secondary relation to malignancy is studied. Our data are in concordance with other epidemiological studies, that showed no influence on breast mitosis and apoptosis a
Autor:
Guo, Jun1 (AUTHOR), Shi, Xiaoyu2 (AUTHOR), Yu, Fei1 (AUTHOR), Cao, Jing Hong1 (AUTHOR), Xia, Enlan3 (AUTHOR), Zhai, Jianjun1 (AUTHOR), Mol, Ben W. J.4,5 (AUTHOR), Li, Tin-Chiu3 (AUTHOR) tinchiu.li@gmail.com
Publikováno v:
Human Fertility. Oct2023, Vol. 26 Issue 4, p797-814. 18p.
Autor:
V. A. Tzingounis
Publikováno v:
JAMA: The Journal of the American Medical Association. 239:1638-1641
Publikováno v:
The Journal of reproductive medicine. 21(3)
One hundred thirty-five women with benign breast disease (BBD) were treated with danazol, an impeded androgen. Their ages ranged from 19 to 60 years (mean age, 30). The dose varied from 100 to 800 mg per day for 90 to 180 days, depending upon the sev
Publikováno v:
International journal of fertility. 24(4)
Prolactin and pituitary gonadotropin levels were studied in eight patients with polycystic ovarian syndrome. All women were of reproductive age and had had menstrual disorders since menarche. Three patients had hyperprolactinemia with or without gala
Publikováno v:
Acta endocrinologica. Supplementum. 233
Oestrogen replacement therapy relieves many post-menopausal symptoms and has been successfully employed clinically for this purpose for more than four decades. Recently the alleged relationship between oestrogens and cancer has stimulated a re-evalua
Autor:
Georgopoulos, N. A.1,2, Papapetropoulos, S.3, Chroni, E.3, Papadeas, E. S.4, Dimopoulos, P. A.5, Kyriazopoulou, V.6, Davis, M. B.7, Eunson, L.7, Kourounis, G.2, Tzingounis, V. A.2
Publikováno v:
Gynecological Endocrinology. Aug2004, Vol. 19 Issue 2, p105-110. 6p.